Skip to main content
Premium Trial:

Request an Annual Quote

Tecan, Innovatis Ink Co-marketing Plan

NEW YORK (GenomeWeb News) – Tecan said today that it will collaborate with Innovatis to jointly market robotic cell culture workstations and cell detection devices.

Under the agreement, the companies will co-market Innovatis' Cellavista automated image-based cellular analysis platform and Tecan's Freedom EVO platform. Used together, Tecan said, the platforms allow automation of a wide range of cell-related processes including cell line development, cell proliferation, stem cell differentiation, and cell-based assays.

Matthew Robin, Tecan's senior VP and head of liquid handling and robotics, said that most Cellavista customers "recognize the advantages of having a liquid handling and cell culture system that complements the detection capabilities of the Cellavista."

Last month, Roche said that it would acquire Bielefeld, Germany-based Innovatis for €15 million ($20.5 million) in a bid to strengthen its position in the bioproduction and cell-fermentation quality-control markets.

Filed under

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.